1. Health

Discuss in my forum

Carol Eustice

Sandoz Recalls Two Lots of Injectable Methotrexate

By May 22, 2013

Follow me on:

The FDA has announced that Sandoz is conducting a voluntary nationwide recall of two lots of its Methotrexate Sodium, USP, 25 mg/mL, 40 mL vial injectable product in the U.S. The recall was initiated after particulate matter in vials was discovered during routine quality examination of retention samples at the manufacturer. According to the FDA, injection of methotrexate from the affected lots can lead to formation of a microembolus (small obstruction) in areas where the particles lodge. Clinical symptoms are not to be expected from the microemboli and Sandoz is not aware of any reports of related adverse events.

The lot numbers and expiration dates of the two recalled lots are CL0996 (expiration date 12/2013) and CJ4948 (expiration date 05/2013). The lots were distributed across the U.S. and to Poland. For more information or if you have questions, check out the FDA MedWatch report.

Related Articles:

Follow Me:

Facebook | Twitter | Message Board | Newsletter

Comments
June 16, 2013 at 1:12 am
(1) vitamin b12 food sources says:

I really like it when individuals come together and share views.

Great website, keep it up!

Leave a Comment

Line and paragraph breaks are automatic. Some HTML allowed: <a href="" title="">, <b>, <i>, <strike>

©2014 About.com. All rights reserved.

We comply with the HONcode standard
for trustworthy health
information: verify here.